Home › Research › Topics › potentiation
potentiation
4 studies tagged potentiation, dated 2006-11-29 to 2021-09-29. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease 2021-09-29
- Role of constitutive calcium-independent phospholipase A2 beta in hippocampo-prefrontal cortical long term potentiation and spatial working memory 2014-08-30
- Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation 2009-08-26
Studies
4 studies carry this tag.
Date range
2006 to 2021
Top journals
- Journal of neuroinflammation 1
- Neurochemistry international 1
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1
- Proceedings of the National Academy of Sciences of the United States of America 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Our findings support the therapeutic potential of modulating, rather than suppressing, neuroinflammation in Alzheimer's disease.
-
Calcium independent phospholipase A2 (iPLA2) is an 85 kDa protein that catalyzes the hydrolysis of the sn-2 acyl ester bond of glycerophospholipids to liberate free fatty acids and lysophospholipids.
-
36/100
The forebrain cholinergic system promotes higher brain function in part by signaling through the M(1) muscarinic acetylcholine receptor (mAChR).
-
Galantamine, a drug for Alzheimer's disease, is a novel cholinergic agent with a dual mode of action, which inhibits acetylcholinesterase and allosterically modulates nicotinic acetylcholine receptors (nAChRs), as a result stimulates catecholamine neurotransmission.